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ABSTRACT
Purpose: Ethiopia is highly trachoma endemic. Baseline mapping was needed in Ethiopia’s Somali
Region to guide elimination efforts.
Methods: Cross-sectional community-based surveys were conducted in 34 suspected trachoma-
endemic woredas, grouped as 14 evaluation units (EUs), using a standardised mapping metho-
dology developed for the Global Trachoma Mapping Project.
Results: In total, 53,467 individuals were enumerated. A total of 48,058 (89.9%) were present at
the time of survey teams’ visits and consented to examination. The prevalence of trachomatous
inflammation–follicular (TF) among children aged 1–9 years ranged from 4.1% in the EU covering
Danot, Boh, and Geladin woredas in Doolo Subzone to 38.1% in the EU covering Kebribeyah and
Hareshen woredas in Fafan Subzone (East). The trichiasis prevalence among adults aged over
15 years varied from 0.1% in the EU covering Afder, Bare, and Dolobay woredas in Afder Subzone
(West) to 1.2% in the EU covering Awbere in Fafan Subzone (West).
Conclusion: Mass drug administration (MDA) with azithromycin is needed in 13 EUs (population
2,845,818). Two EUs (population 667,599) had TF prevalences in 1–9-year-olds of ≥30% and will
require at least 5 years of MDA; 5 EUs (population 1,1193,032) had TF prevalences of 10–29.9%
and need at least three years of MDA; 6 EUs (population 985,187) had TF prevalences of 5–9.9%
and need at least one round of azithromycin distribution before re-survey. In all 13 of these EUs,
implementation of facial cleanliness and environmental improvement measures is also needed.
Surveys are still needed in the remaining 34 unmapped woredas of Somali Region.
KEYWORDS
Trachoma; prevalence;
trichiasis; epidemiology;
Global Trachoma Mapping
Project
Introduction
According to a published estimate, there were 32 mil-
lion blind individuals and 191 million people with
moderate-to-severe visual impairment worldwide in
2010.1 Trachoma is the leading infectious cause of
blindness, especially in populations that have poor
environmental sanitation, inadequate water supply,
and poor socio-economic status.2,3 More than 80% of
the global burden of active trachoma is concentrated in
14 countries, all of which are in Africa.4 Ethiopia is the
second most populous country in Africa and has a very
high burden of trachoma.5
Worldwide, considerable progress has been made in
trachoma elimination. The Ethiopian government has
endorsed the World Health Assembly-supported goal
of global elimination of trachoma as a public health
problem by the year 2020 (GET2020), yet planning for
and progress in elimination has been hampered by the
low coverage of existing surveys.
The 2005–2006 Ethiopian National Survey on
Blindness, Low Vision and Trachoma estimated
region-level trachoma prevalences for Ethiopian
Somali Region of 16.7% trachomatous inflammation–
follicular (TF) in children aged 1–9 years, and 4.2%
trachomatous trichiasis (TT) in adults aged 15 years
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and above.6 However, according to WHO recommen-
dations, district-level prevalence data are generally
necessary for determining the need for implementation
of the SAFE (surgery, antibiotics, facial cleanliness,
environmental improvement) strategy for trachoma
elimination.7,8 “Districts” in this recommendation are
defined as “the administrative unit for health care
management” which “for purposes of clarification con-
sists of a population unit between 100,000 and 250,000
persons”.9 However, where trachoma is expected to be
highly and widely endemic, baseline surveys can frame
larger populations, so that interventions can be pro-
vided to those most in need in a timely manner.
A true picture of trachoma prevalence will direct
regional priorities for Somali Region’s blindness control
programme, provide baseline data for monitoring and
evaluation, and help guide those fighting trachoma to
move swiftly towards meeting the GET2020 goal. In
collaboration with the Global Trachoma Mapping
Project (GTMP), the Ethiopian Somali Regional
Health Bureau conducted population-based trachoma
prevalence surveys throughout the region, using the
standardised GTMP protocol.10
Methods
Setting
Ethiopian Somali Region is one of nine regional states that
make up the Federal Democratic Republic of Ethiopia. It
occupies an area of about 350,000 km2 and is divided into
nine zones (Figure 1). These zones are further divided
into 68 woredas (districts) and 4 city councils. According
to the Central Statistical Authority’s 2007 Population and
Housing Census, the total population of the region was
4.40 million in 2007.11
Thirty four of the region’s 68 woredas were identi-
fied as suspected-trachoma-endemic, secure and acces-
sible to survey teams. Trachoma was expected to be
highly and widely endemic, so the 34 woredas were
grouped to form 14 evaluation units (EUs) of up to
500,000 inhabitants each, respecting existing adminis-
trative boundaries insofar as was possible (Figure 1).
Survey design
Each survey followed a two-stage cluster-random sam-
pling methodology designed to generate EU-level pre-
valence estimates for TF in children aged 1–9 years, and
trichiasis in persons aged 15 years and above. In each
EU, clusters were defined as villages, and a sampling
frame of all villages in the EU was obtained from
district head offices. In the first sampling stage, 26
villages were selected using probability proportional to
size sampling. In the second stage, on the day of survey
at each cluster, 30 households were selected using com-
pact segment sampling. All residents of selected house-
holds aged 1 year or above were invited to participate.
Full details of the sample size and the specifics of the
survey design are outlined elsewhere.10
Figure 1. Evaluation units for trachoma surveys, Global Trachoma Mapping Project, Somali Region, Ethiopia, 2013. Woredas and
administrative zones are labelled.
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Fieldwork
Prior to fieldwork, all 10 trachoma graders and all 10 data
recorders completed the GTMP version 1 training course
and passed their respective GTMP examinations. Full
details of training and testing are outlined elsewhere.10
Community sensitisation was carried out a few days in
advance of the survey. Each selected cluster was visited by a
survey coordinator, who briefed the village chief and com-
munity members and prepared the sampling frame for
random segment selection by the survey team. On the day
of the survey, at each selected household, consent to survey
was obtained from the household head. All household
members were enumerated, and present and consenting
individuals were examined using sunlight and 2.5× magni-
fying loupes (Binomag Plastic, USA), for the presence or
absence of TF, trachomatous inflammation–intense (TI)
and trichiasis using theWHO simplified trachoma grading
system.12,13 Global Positioning System (GPS) coordinates
were recorded at each household for quality control
purposes.
Two experienced ophthalmologists were employed
as supervisors throughout the mapping, with field visits
to each team at least once every 5 days. All field data
were recorded in Android devices running the LINKS
application (Task Force for Global Health, Decatur GA,
USA).10,14 Upon completion of fieldwork each day, the
recorder uploaded data from the phone over an
encrypted connection to the GTMP secure server.
Subsequent data processing and approval was under-
taken as described elsewhere.10
Data processing and analysis
All data analysis, which included replication of auto-
mated analyses undertaken centrally within the GTMP,
was carried out using SPSS Version 20.0 statistical soft-
ware (IBM Corp, Armonk, NY, USA, 2011). TF pre-
valences were adjusted for age in 1 year age groups, and
trichiasis prevalences were adjusted for sex and age in
5 year age groups10, using the latest available census
data.11 EU-level prevalence estimates were calculated as
the means of all cluster-level estimates of the same
outcome. This accounted for unanticipated variability
in the numbers examined at each cluster, but equally
weighting all clusters. Prevalence estimates for all EUs
combined (project-level estimates) were calculated as
means of all EU-level outcome estimates.
To account for the clustered design of the survey,
confidence intervals for EU-level estimates were calcu-
lated by bootstrapping adjusted cluster-level estimates.
Confidence intervals for project-level estimates were
calculated by bootstrapping adjusted cluster-level
estimates with the inclusion of stratification of clusters
by EU. Both EU- and project-level confidence intervals
were estimated over 10,000 bootstrapping iterations, by
taking the 2.5th and 97.5th centiles of these results.
Logistic regression was used to investigate age and sex
associations with trichiasis.
Ethical considerations
Ethical approval was obtained from the ethics committee of
the London School of Hygiene & Tropical Medicine
(Protocol no. 6319), and the Somali Regional State Health
Bureau Ethics Committee (Protocol no. KS/we/01892/06).
Informed verbal consent was obtained from all adult parti-
cipants. For participants under 15 years of age, informed
verbal consent was obtained from a parent or guardian.
Individuals found to have active trachoma (TF ± TI) were
offered treatment with 1% tetracycline eye ointment and
individuals with trichiasis were referred for management.
Results
Training and fieldwork were conducted between February
and July 2013. A total of 364 clusters were visited. From
10,955 selected households, 53,467 individuals were enum-
erated; 48,058 (89.9%) people were present and examined
by the survey team, 5365 (10%) individuals were absent,
and 42 (0.1%) refused to participate. 23,620 (44.2%) of
those enumerated were children aged 1–9 years (Table 1).
The median age of those enumerated was 12 years (25th
centile: 5, 75th centile: 31). The sex distribution of those
examined was 46.2% male and 53.8% female.
In 1–9-year-olds, the highest age-specific proportion
of TF cases (21.4%) was noted in children aged 2 years,
with the burden of TF decreasing with increasing age
thereafter (χ2 for trend = 799.0, P < 0.0001). Similarly,
the prevalence of TI decreased with increasing age,
although this trend was not statistically significant (χ2
for trend = 3.6, P = 0.055) (Figure 2).
Table 2 shows the prevalence of TF and TI in chil-
dren aged 1–9 years in each EU. The TF prevalence in
children aged 1–9 years by EU is shown in Figure 3.
The overall age-adjusted TF prevalence in children aged
1–9 years for all project EUs combined was 13.7% (95%
Table 1. Age and sex distribution of enumerated individuals,
Global Trachoma Mapping Project, Somali Region, Ethiopia,
2013.
Age (years)
1–9 10–14 15+ Total
Female 12158 2833 11291 27,185 (50.8%)
Male 11462 2380 13343 26,282 (49.2%)
Total 23620 5213 24634 53467 (100%)
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CI; 12.1–14.8). TF prevalence was particularly high in
the EU covering Awbere woreda in Fafan Subzone
(East) (38.1%) and in the EU covering Awbere woreda
in Fafan Subzone (West) (33.1%). The overall project-
level age-adjusted prevalence of TI in children aged
1–9 years was 1.7% (95% CI; 1.2–2.4). There was
marked variation in the TI prevalence in this agegroup
between EUs. The highest prevalences were in the EU
covering Awbere woreda in Fafan Subzone (West)
(7.0%), and the EU covering Kebribeyah and
Hareshen woredas in Fafan Subzone (East) (6.8%).
The project-level age- and sex-adjusted prevalence of
trichiasis among those aged 15+ years was 0.5% (95%
CI; 0.4–0.7). The estimated trichiasis prevalence was
Figure 2. Age-specific prevalences of trachomatous inflammation–follicular (TF) and trachomatous inflammation–intense (TI) in
children aged 1–9 years, Global Trachoma Mapping Project, Somali Region, Ethiopia, 2013.
Table 2. Prevalence of trachomatous inflammation–follicular (TF) and trachomatous inflammation–intense (TI) among children aged
1–9 years, Global Trachoma Mapping Project, Somali Region, Ethiopia, 2013.
Evaluation unit Zone
TF+ (1–9) number of cases,
(unadjusted %)
TF+ (1–9)
adjusteda (%) 95% CI
TI+ (1–9)
number of
cases,
(unadjusted %)
TI+ (1–9)
adjusteda (%) 95%CI
Afder, Bare, Dolobay Afder Subzone
(West)
213 (11.4%) 10.7 [6.3–17.7] 6 (0.3%) 0.35 [0.0–0.7]
Guradamole, Goro Baqaqsa,
Chereti/Weyib
Afder Subzone
(Central)
224 (12.7%) 11.3 [6.2–14.2] 3 (0.2%) 0.14 [0.0–0.5]
Jijiga Rural, Gursum, Babile Fafan Subzone
(Central)
273 (21.1%) 18.5 [12.7–25.3] 21 (1.6%) 1.31 [0.3–2.7]
Kebribeyah, Hareshen Fafan Subzone
(East)
578 (42.1%) 38.1 [30.4–45.1] 93 (6.8%) 6.77 [2.7–12.6]
Maeso, Erer, Shinile Sity Subzone
(Central)
150 (10.2%) 8.8 [4.8–13.6] 11 (0.7%) 0.71 [1.4–9.6]
Afdem, Ayisha, Dembel Sity Subzone
(West)
125 (8.6%) 8 [4.9–13.3] 76 (5.2%) 5.45 [1.4–9.6]
Gashamo, Aware Korahe and jerer
Subzone
111 (5.7%) 5.6 [2.7–9.1] 0 (0.0%) 0 [0.0–0.0]
Danot, Boh, Geladin Doolo Subzone 94 (4.7%) 4.1 [1.9–8.7] 4 (0.2%) 0.16 [0.0–0.4]
Gode, Adadle Shebelle zone 151 (7.5%) 7.2 [3.9–10.4] 2 (0.1%) 0.08 [0.0–0.3]
Elkere, West Imi Afder Subzone
(East)
154 (8.3%) 7.5 [3.9–11.9] 5 (0.3%) 0.35 [0.6–3.9]
Moyale Liben Subzone
(West)
214 (13.9%) 12.6 [7.5–16.3] 37 (2.4%) 2.17 [0.4–2.0]
Hudet, Dolo Odo Liben & Afder
(Central)
306 (19.1%) 16.9 [12.1–20.5] 20 (1.2%) 1.07 [0.4–2.0]
Filtu Liben & Afder
(West)
152 (10%) 8.9 [5.6–12.5] 8 (0.5%) 0.44 [0.1–0.8]
Awbere Fafan Subzone
(West)
426 (35.9%) 33.1 [22.0–40.2] 87 (7.3%) 6.95 [1.4–12.0]
a Adjusted for age based on 2007 Central Statistical Authority (CSA) census data.
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highest in the EU covering Awbere in Fafan Subzone
(West) (1.2%) and the EU covering Jijiga Rural,
Gursum, and Babile woredas in Fafan Subzone
(Central) (1.1%) (Table 3, Figure 4).
Overall, after adjusting for age, females had 3.4 times
higher odds of having trichiasis than males (Likelihood
ratio test; OR = 3.43, 95%CI [2.6 –4.5], p-value<0.0001).
Discussion
Our data have important implications for implementa-
tion of the SAFE strategy in the Ethiopian Somali Region.
There was significant variation in the prevalence of TF,
TI, and trichiasis across the 14 EUs studied. Among adults
aged over 15 years, the Fafan Zone overall had the EUs
with the highest trichiasis prevalences, and delivery of
community-based trichiasis surgery services in these
areas is a public health emergency. In other EUs, the
overall need is less pressing, but every individual with
trichiasis should be offered an operation to correct it as
soon as possible, in order to limit the risk of irreversible
visual impairment. In our surveys, trichiasis was far more
likely to be found in women. This excess risk of trichiasis
in women compared to men has been found in other
Figure 3. Prevalence of trachomatous inflammation–follicular (TF) in children aged 1–9 years, Global Trachoma Mapping Project,
Somali Region, Ethiopia, 2013.
Table 3. Prevalence of trichiasis among adults aged over 15 years, Global Trachoma Mapping Project, Somali Region, Ethiopia, 2013.
Evaluation unit Zone
Trichiasis (15+), number of cases
(unadjusted %)
Trichiasis (15+) Adjusteda
(%)
95% Confidence
interval
Afder, Bare, Dolobay Afder Subzone (West) 7 (0.5%) 0.1 [0.0–0.2]
Guradamole, Goro Baqaqsa,
Chereti/Weyib
Afder Subzone (Central) 18 (1.3%) 0.7 [0.3–1.4]
Jijiga Rural, Gursum, Babile Fafan Subzone (Central) 39 (2.7%) 1.1 [0.5–1.9]
Kebribeyah, Hareshen Fafan Subzone (East) 19 (1.3%) 0.3 [0.2–0.6]
Maeso, Erer, Shinile Sity Subzone (Central) 22 (1.4%) 1.0 [0.4–1.8]
Afdem, Ayisha, Dembel Sity Subzone (West) 7 (0.5%) 0.2b [0.1–0.3]
Gashamo, Aware Korahe and Jerer
Subzone
2 (0.1%) 0.0 [0.0–0.1]
Danot, Boh, Geladin Doolo Subzone 6 (0.4%) 0.2 c [0.0–0.5]
Gode, Adadle Shebelle zone 7 (0.5%) 0.2b [0.0–0.4]
Elkere, West Imi Afder Subzone (East) 9 (0.6%) 0.2 c [0.1–0.4]
Moyale Liben Subzone (West) 30 (2.1%) 0.8 [0.4–1.4]
Hudet, Dolo Odo Liben & Afder (Central) 38 (2.6%) 1.0 [0.6–1.4]
Filtu Liben & Afder (West) 12 (0.8%) 0.2 c [0.1–0.5]
Awbere Fafan Subzone (West) 45 (3.1%) 1.2 [0.6–2.1]
aAdjusted for sex and age in 5 year bands based on 2007 Central Statistical Authority (CSA) census data.
bRounded up to 0.2%
cRounded down to 0.2%
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surveys15–23 and is presumed to stem frommore frequent
infection of women with ocular C. trachomatis infection,
due to their greater exposure to children, the main infec-
tion reservoir.24 Specific measures to increase women’s
access to trichiasis surgery are needed here.
Based on TF prevalences in 1–9 year-olds, and fol-
lowing WHO recommendations, Kebribeyah and
Hareshen woredas in Fafan Subzone (East) and
Awbere woreda in Fafan sub zone (West), need five
years of A, F, and E implementation prior to an impact
survey; 5 EUs require three years of A, F, and E imple-
mentation before impact surveys; and 6 EUs warrant a
single round of azithromycin in the first instance,
together with implementation of the F and E compo-
nents of SAFE, before re-survey.
It will be noted that there is a large block of central
Somali Region, comprising some 21 woredas, for which
we currently have no data on trachoma prevalence
(Figures 3 and 4). This is an important limitation to
our work as a whole. Whether or not the current
absence of data from these areas will affect prospects
for trachoma elimination from Ethiopia will depend on
whether trachoma is present there, on the extent of
population movement between that area and other
areas of the country, and the length of time that elapses
before the necessary data are acquired, and interven-
tions—if needed—can be commenced.
In conclusion, the prevalence of active trachoma in
Ethiopian Somali region is high, with 13 of 14 EUs
surveyed needing at least one round of MDA with
azithromycin, plus implementation F and E. The tri-
chiasis prevalence was high in four EUs and significant
scale-up of efforts to train surgeons to address the
backlog of trichiasis surgeries is needed urgently. To
achieve the goal of GET2020, further baseline mapping
will also be needed in the unmapped woredas of Somali
Region, once security has improved.
Declaration of interest
The authors report no conflicts of interest. The authors alone
are responsible for the content and writing of the paper.
Funding
This study was principally funded by the Global Trachoma
Mapping Project (GTMP) grant from the United Kingdom’s
Department for International Development (ARIES: 203145)
to Sightsavers, which led a consortium of non-governmental
organisations and academic institutions to support ministries
of health to complete baseline trachoma mapping worldwide.
The GTMP was also funded by the United States Agency for
International Development (USAID), through the
ENVISION project implemented by RTI International
under cooperative agreement number AID-OAA-A-11-
00048, and the END in Asia project implemented by
FHI360 under cooperative agreement number OAA-A-10-
00051. A committee established in March 2012 to examine
issues surrounding completion of global trachoma mapping
was initially funded by a grant from Pfizer to the
Figure 4. Prevalence of trichiasis among adults aged over 15 years, Global Trachoma Mapping Project, Somali Region, Ethiopia, 2013.
30 A. B. DUALE ET AL.
International Trachoma Initiative. AWS was a Wellcome
Trust Intermediate Clinical Fellow (098521) at the London
School of Hygiene & Tropical Medicine. None of the funders
had any role in project design, in project implementation or
analysis or interpretation of data, in the decisions on where,
how or when to publish in the peer reviewed press, or in
preparation of the manuscript.
Notes on contributors
ABD oversaw field work, interpreted the data, and drafted the
manuscript. NNA and RW analysed the data. BK reviewed the
data. RMF provided key geographical information system input.
CKM, MD, and AWS designed the sampling and analysis and
provided technical oversight; AWS is Chief Scientist to the
GTMP. ABK, WA, and PAM trained the survey teams. All
authors reviewed the draft manuscript critically for intellectual
content, and read and approved the final version.
References
1. Bourne RRA, Stevens GA, White RA, et al. Causes of
vision loss worldwide 1990-2010: a systematic analysis.
Lancet Glob Health. 2013; 1(6):e339–e349.
2. Mariotti SP, Pascolini D, Rose-Nussbaumer J.
Trachoma: global magnitude of a preventable cause of
blindness. Br J Ophthalmol. 2009; 93(5):563–568.
3. BurtonMJ. Trachoma: an overview. BrMed Bull. 2007; 84:
99–116.
4. Haddad D. Trachoma: the beginning of the end?
Community Eye Health. 2012; 25(77): 18.
5. FederalMinistry of Health of Ethiopia.National Trachoma
Action Plan. Addis Ababa: Federal Democratic Republic of
Ethiopia; 2012.
6. Berhane Y, Alemayehu W, Bejiga A. National Survey
on Blindness, Low Vision and Trachoma in Ethiopia.
Addis Ababa: Federal Ministry of Health of Ethiopia;
2006.
7. Bailey R, Lietman T. The SAFE strategy for the elim-
ination of trachoma by 2020: Will it work? Bull World
Health Organ. 2001; 79(3): 233–236.
8. West SK. Blinding trachoma: prevention with the SAFE
strategy. Am J Trop Med Hyg. 2003; 69(5 Suppl): 18–23.
9. World Health Organization. Report of the 3rd global
scientific meeting on trachoma, Johns Hopkins
University, Baltimore, MA, 19-20 July 2010. Geneva:
World Health Organization; 2010.
10. Solomon AW, Pavluck A, Courtright P, et al. The
Global Trachoma Mapping Project: Methodology of a
34-country population-based study. Ophthalmic
Epidemiology. 2015; 22(3): 214–225.
11. Central Statistical Agency of Ethiopia. Population and
Housing Census – Somali Region. Addis Ababa: 2007.
12. Thylefors B, Dawson CR, Jones BR, West SK, Taylor
HR. A simple system for the assessment of trachoma
and its complications. Bull World Health Organ. 1987;
65(4): 477–483.
13. Solomon AW, Peeling RW, Foster A, Mabey DCW.
Diagnosis and assessment of trachoma. Clin Microbiol
Rev. 2004;17(4): 982–1011.
14. Pavluck A, Chu B, Mann Flueckiger R, Ottesen E.
Electronic data capture tools for global health pro-
grams: evolution of LINKS, an android-, web-based
system. PLoS Negl Trop Dis. 2014; 8(4):e2654.
15. King JD, Jip N, Jugu YS, et al. Mapping trachoma in
Nasarawa and Plateau States, central Nigeria. Br J
Ophthalmol. 2010;94(1): 14–19.
16. Kalua K, Singini I, Mukaka M, Senyonjo L. The epide-
miology of trachoma in the lower shire valley of south-
ern Malawi and implications for the SAFE strategy. Int
J Trop Dis Heal. 2014; 4(5): 494–508.
17. Faal H, Minassian D, Sowa S, Foster A. National survey
of blindness and low vision in The Gambia: results. Br J
Ophthalmol. 1989; 73(2): 82–87.
18. Smith JL, Sivasubramaniam S, Rabiu MM, Kyari F,
Solomon AW, Multilevel GC. Analysis of trachoma-
tous trichiasis and corneal opacity in Nigeria: The
role of environmental and climatic risk factors on
the distribution of disease. PLoS Negl Trop Dis.
2015; 9: 7.
19. Mpyet C, N M, AdamuMD, et al. Prevalence of trachoma
in Katsina State, Nigeria: results of 34 district-level surveys.
Ophthalmic Epidemiol. 2016; 23(sup1): 55–62.
20. Bero B, Macleod C, Alemayehu W, et al. Prevalence of
and risk factors for trachoma in Oromia regional State
of Ethiopia: results of 79 population-based prevalence
surveys conducted with the global trachoma mapping
project. Ophthalmic Epidemiol. 2016; 23(6): 392–405.
21. Mpyet C, Muhammad N, Adamu MD, et al. Prevalence
of trachoma in Bauchi State, Nigeria: results of 20 local
government area-level surveys. Ophthalmic Epidemiol.
2016; 23(sup1): 39–45.
22. Elshafie BE, Osman KH, Macleod C, et al. The epide-
miology of trachoma in Darfur states and Khartoum
state, Sudan: results of 32 population-based prevalence
surveys. Ophthalmic Epidemiol. 2016; 23(6): 381–391.
23. Adamu Y, Macleod C, Adamu L, et al. Prevalence of
trachoma in Benishangul Gumuz Region, Ethiopia:
results of seven population-based surveys from the
global trachoma mapping project. Ophthalmic
Epidemiol. 2016; 23(sup1): 70–76.
24. Solomon AW, Holland MJ, Burton MJ, et al.
Strategies for control of trachoma: observational
study with quantitative PCR. Lancet. 2003;362
(9379): 198–204.
Appendix
The Global Trachoma Mapping Project Investigators are:
Agatha Aboe (1,11), Liknaw Adamu (4), Wondu
Alemayehu (4,5), Menbere Alemu (4), Neal D. E. Alexander
(9), Berhanu Bero (4), Simon J. Brooker (1,6), Simon Bush
(7,8), Brian K. Chu (2,9), Paul Courtright (1,3,4,7,11),
Michael Dejene (3), Paul M. Emerson (1,6,7), Rebecca M.
Flueckiger (2), Allen Foster (1,7), Solomon Gadisa (4),
Katherine Gass (6,9), Teshome Gebre (4), Zelalem Habtamu
(4), Danny Haddad Kalua (5), Amir B. Kello (4,5), Jonathan
D. King (6,10,11), Richard Le Mesurier (4,7), Susan Lewallen
(4,11), Thomas M. Lietman (10), Chad MacArthur (6,11),
Colin Macleod (3,9), Silvio P. Mariotti (7,11), Anna Massey
(8), Els Mathieu (6,11), Siobhain McCullagh (8), Addis
OPHTHALMIC EPIDEMIOLOGY 31
Mekasha (4), Tom Millar (4,8), Caleb Mpyet (3,5), Beatriz
Muñoz (6,9), Jeremiah Ngondi (1,3,6,11), Stephanie Ogden
(6), Alex Pavluck (2,4,10), Joseph Pearce (10), Serge Resnikoff
(1), Virginia Sarah (4), Boubacar Sarr (5), Alemayehu Sisay
(4), Jennifer L. Smith (11), Anthony W. Solomon
(1,2,3,4,5,6,7,8,9,10,11), Jo Thomson (4), Sheila K. West
(1,10,11), Rebecca Willis (2,9).
Key: (1) Advisory Committee, (2) Information Technology,
Geographical Information Systems, and Data Processing, (3)
Epidemiological Support, (4) Ethiopia Pilot Team, (5) Master
Grader Trainers, (6) Methodologies Working Group, (7)
Prioritisation Working Group, (8) Proposal Development,
Finances and Logistics, (9) Statistics and Data Analysis, (10)
Tools Working Group, (11) Training Working Group.
32 A. B. DUALE ET AL.
